Abstract
The purpose of this study was to evaluate the role of regional intraarterial thrombolytic therapy (IATT) followed by percutaneous transluminal angioplasty (PTA) in the management of acute limb-threatening ischemia. From March 1989 to July 1994, 28 of the 130 (22%) patients who underwent IATT had lesions amendable to immediate PTA. The duration of ischemia was less than seven days in all patients. PTA was performed for multiple lesions in 15 (54%) patients to yield a total of 46 stenotic areas. Stenoses were all less than 5 cm in length (mean: 2.1 cm). A mean follow-up period of 17.6 months was achieved in all patients. Immediate PTA success was achieved in 25 of 28 (89%) patients. Primary patency rates at 6-, 12-, 18-, and 24-month intervals were 63%, 49%, 31%, and 23%, respectively. Secondary patency rates at the same time intervals were 79%, 65%, 59%, and 52%, respectively. The limb-salvage rate was 64% at 12 months. Secondary surgical procedures were performed in 12 (43%) patients at a mean interval of 336 days from time of PTA. In patients with poor run-off (zero to one vessel patent), six-month primary patency rate was 33% compared to 77% in patients with good run-off (two to three vessels patent) (P < 0.05). PTA following IATT for limb-threatening ischemia is associated with limited long-term patency rates, particularly in patients with poor run-off.
Get full access to this article
View all access options for this article.